Correlation between SARS-COV-2 antibody screening by immunoassay and neutralizing antibody testing.
Alfredo Mendrone-JuniorCarla Luana DinardoSuzete Cleuza FerreiraAnna Shoko NishiyaNanci Alves SallesCesar de Almeida NetoDebora Toshei HamasakiTila FacincaniLucas Bassolli de Oliveira AlvesRafael Rahal Guaragna MachadoDanielle Bastos AraujoEdison Luiz DurigonVanderson RochaEster Cerdeira SabinoPublished in: Transfusion (2021)
SARS-CoV-2 IgG immunoassays (S/CO) can be used to predict high anti-SARS-CoV-2 nAbs titers. This study has proposed different criteria for identifying donors with ≥1:160 nAbs titers, all with high efficacy.